Altamira Therapeutics Ownership 2024 | Who Owns Altamira Therapeutics Now?
Institutional Ownership
3.13%
Insider Ownership
0.89%
Retail Ownership
95.98%
Institutional Holders
11.00
Altamira Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
CITIGROUP INC | 81.97% | - | 3,074 | 3,074 | 100.00% | 3,935,000 | Mar 31, 2023 |
UBS GROUP AG | 40.85% | - | 1,532 | -2,315 | -60.18% | 1,961,000 | Mar 31, 2023 |
MORGAN STANLEY | 27.33% | - | 1,025 | -1,470 | -58.92% | 1,312,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.67% | - | 25 | - | - | 32,000 | Mar 31, 2023 |
ADVISOR GROUP HOLDINGS, INC. | 0.40% | - | 15 | 15 | 100.00% | 19,000 | Mar 31, 2023 |
STONEBRIDGE CAPITAL ADVISORS LLC | 0.13% | - | 5 | - | - | 6,000 | Mar 31, 2023 |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | - | - | - | -10,100 | -100.00% | - | Mar 31, 2023 |
GROUP ONE TRADING, L.P. | - | - | - | -748 | -100.00% | - | Mar 31, 2023 |
Altamira Therapeutics's largest institutional shareholder is CITIGROUP INC, holding 81.97% of the company's total share outstanding, currently valued at $3.94M. The top 10 institutional shareholders own together 151.36% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
CITIGROUP INC | 81.97% | - | 3,074 | 3,074 | 100.00% | 3,935,000 | Mar 31, 2023 |
UBS GROUP AG | 40.85% | - | 1,532 | -2,315 | -60.18% | 1,961,000 | Mar 31, 2023 |
STONEBRIDGE CAPITAL ADVISORS LLC | 0.13% | - | 5 | - | - | 6,000 | Mar 31, 2023 |
MORGAN STANLEY | 27.33% | - | 1,025 | -1,470 | -58.92% | 1,312,000 | Mar 31, 2023 |
ADVISOR GROUP HOLDINGS, INC. | 0.40% | - | 15 | 15 | 100.00% | 19,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.67% | - | 25 | - | - | 32,000 | Mar 31, 2023 |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | - | - | - | -10,100 | -100.00% | - | Mar 31, 2023 |
GROUP ONE TRADING, L.P. | - | - | - | -748 | -100.00% | - | Mar 31, 2023 |
The largest Altamira Therapeutics shareholder by % of total assets is CITIGROUP INC. The company owns 3.07K shares of Altamira Therapeutics (CYTO), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
CITIGROUP INC | 81.97% | - | 3,074 | 3,074 | 100.00% | 3,935,000 | Mar 31, 2023 |
ADVISOR GROUP HOLDINGS, INC. | 0.40% | - | 15 | 15 | 100.00% | 19,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.67% | - | 25 | - | - | 32,000 | Mar 31, 2023 |
STONEBRIDGE CAPITAL ADVISORS LLC | 0.13% | - | 5 | - | - | 6,000 | Mar 31, 2023 |
GROUP ONE TRADING, L.P. | - | - | - | -748 | -100.00% | - | Mar 31, 2023 |
MORGAN STANLEY | 27.33% | - | 1,025 | -1,470 | -58.92% | 1,312,000 | Mar 31, 2023 |
UBS GROUP AG | 40.85% | - | 1,532 | -2,315 | -60.18% | 1,961,000 | Mar 31, 2023 |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | - | - | - | -10,100 | -100.00% | - | Mar 31, 2023 |
As of Mar 31 2023, Altamira Therapeutics's largest institutional buyer is CITIGROUP INC. The company purchased 3.07K stocks of CYTO, valued at $3.94M.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
SUSQUEHANNA INTERNATIONAL GROUP, LLP | - | - | - | -10,100 | -100.00% | - | Mar 31, 2023 |
UBS GROUP AG | 40.85% | - | 1,532 | -2,315 | -60.18% | 1,961,000 | Mar 31, 2023 |
MORGAN STANLEY | 27.33% | - | 1,025 | -1,470 | -58.92% | 1,312,000 | Mar 31, 2023 |
GROUP ONE TRADING, L.P. | - | - | - | -748 | -100.00% | - | Mar 31, 2023 |
STONEBRIDGE CAPITAL ADVISORS LLC | 0.13% | - | 5 | - | - | 6,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.67% | - | 25 | - | - | 32,000 | Mar 31, 2023 |
ADVISOR GROUP HOLDINGS, INC. | 0.40% | - | 15 | 15 | 100.00% | 19,000 | Mar 31, 2023 |
CITIGROUP INC | 81.97% | - | 3,074 | 3,074 | 100.00% | 3,935,000 | Mar 31, 2023 |
As of Mar 31 2023, Altamira Therapeutics's biggest institutional seller is SUSQUEHANNA INTERNATIONAL GROUP, LLP. The company sold -10.10K shares of CYTO, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
CITIGROUP INC | 81.97% | - | 3,074 | 3,074 | 100.00% | 3,935,000 | Mar 31, 2023 |
ADVISOR GROUP HOLDINGS, INC. | 0.40% | - | 15 | 15 | 100.00% | 19,000 | Mar 31, 2023 |
Altamira Therapeutics's largest new institutional shareholder by number of shares is CITIGROUP INC, purchased 3.07K shares, valued at $3.94M, as of undefined.
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
SUSQUEHANNA INTERNATIONAL GROUP, LLP | - | - | - | -10,100 | -100.00% | - | Mar 31, 2023 |
GROUP ONE TRADING, L.P. | - | - | - | -748 | -100.00% | - | Mar 31, 2023 |
Altamira Therapeutics's largest sold out institutional shareholder by shares sold is SUSQUEHANNA INTERNATIONAL GROUP, LLP, sold -10.10K shares, valued at -, as of undefined.
Altamira Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
30 Sep, 22 | 11 | - |
30 Jun, 22 | 11 | -26.67% |
31 Mar, 22 | 15 | -16.67% |
31 Dec, 21 | 18 | 12.50% |
30 Sep, 21 | 16 | - |
As of 30 Sep 22, 11 institutions are holding Altamira Therapeutics's shares, representing an increase of 0.00% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
30 Sep, 22 | 414,334 | 40.62% |
30 Jun, 22 | 294,645 | -46.88% |
31 Mar, 22 | 554,714 | -2.09% |
31 Dec, 21 | 566,577 | -15.35% |
30 Sep, 21 | 669,295 | - |
Altamira Therapeutics (CYTO) has 414.33K shares outstanding as of 30 Sep 22, up 40.62% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
30 Sep, 22 | 3.13% | 63.22% |
30 Jun, 22 | 2.22% | 12.68% |
31 Mar, 22 | 4.19% | 22.89% |
31 Dec, 21 | 4.28% | 16.75% |
30 Sep, 21 | 5.05% | - |
As of 30 Sep 22, Altamira Therapeutics is held by 3.13% institutional shareholders, representing a 63.22% growth compared to 30 Jun 22.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
30 Sep, 22 | 6 | -14.29% |
30 Jun, 22 | 7 | -22.22% |
31 Mar, 22 | 9 | - |
31 Dec, 21 | 9 | -40.00% |
30 Sep, 21 | 15 | - |
6 institutional shareholders have increased their position in CYTO stock as of 30 Sep 22 compared to 7 in the previous quarter (a -14.29% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
30 Sep, 22 | 3 | - |
30 Jun, 22 | 3 | 50.00% |
31 Mar, 22 | 2 | -66.67% |
31 Dec, 21 | 6 | - |
30 Sep, 21 | - | - |
3 institutional shareholders have reduced their position in CYTO stock as of 30 Sep 22 compared to 3 in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
30 Sep, 22 | 11 | - | 414,334 | 40.62% | 3.13% | 63.22% | 6 | -14.29% | 3 | - |
30 Jun, 22 | 11 | -26.67% | 294,645 | -46.88% | 2.22% | 12.68% | 7 | -22.22% | 3 | 50.00% |
31 Mar, 22 | 15 | -16.67% | 554,714 | -2.09% | 4.19% | 22.89% | 9 | - | 2 | -66.67% |
31 Dec, 21 | 18 | 12.50% | 566,577 | -15.35% | 4.28% | 16.75% | 9 | -40.00% | 6 | - |
30 Sep, 21 | 16 | - | 669,295 | - | 5.05% | - | 15 | - | - | - |
Altamira Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
All Insider Owners Trades
The last insider sell of Altamira Therapeutics's stock was made by CARTER STEPHEN on May 12 2008, selling 10,000 shares at $0.62 per share (valued at $6.20K).
Altamira Therapeutics Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|
Altamira Therapeutics Peer Ownership
CYTO Ownership FAQ
Who Owns Altamira Therapeutics?
Altamira Therapeutics is owned by institutional shareholders (3.13%), insiders (0.89%), and public (95.98%). The largest institutional shareholder of Altamira Therapeutics is CITIGROUP INC (81.97% of total shares) and the top mutual fund owner is (0% of total shares).
Who are the major institutional shareholders of Altamira Therapeutics?
Altamira Therapeutics's major institutional shareholders are CITIGROUP INC, UBS GROUP AG, MORGAN STANLEY, WELLS FARGO & COMPANY/MN, and ADVISOR GROUP HOLDINGS, INC.. The top five shareholders own together 151.23% of the company's share outstanding.
How many Altamira Therapeutics shareholders are there?
As of Sep 2022, there are 11 institutional shareholders of Altamira Therapeutics.
What percentage of Altamira Therapeutics is owned by CITIGROUP INC?
CITIGROUP INC owns 3.07K shares of Altamira Therapeutics, representing 81.97% of the company's total shares outstanding, valued at $3.94M (as of Mar 2023).
What percentage of Altamira Therapeutics is owned by UBS GROUP AG?
As of Mar 2023, UBS GROUP AG holds 1.53K shares of Altamira Therapeutics (CYTO), compromising 40.85% of the company, valued at $1.96M.
What percentage of Altamira Therapeutics is owned by MORGAN STANLEY?
MORGAN STANLEY is the third largest holder of Altamira Therapeutics. The company owns 1.02K of the company's shares outstanding (worth $1.31M).